Address
Email address
Funktsionaalsed seened, mis on tuntud ka kui meditsiiniseened, on maailmas enim uuritud seenteklass, mida hinnatakse kõrgelt nende tervist turgutavate toimete tõttu – nt on nad võimsad antioksüdandid ja omavad muuseas ka närvirakke arendavaid, immuunsust tugevdavaid ning põletikku vähendavaid omandusi.
Name
Chaga Mets OÜ
Registry code
12884116
VAT number
EE102306411
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.07.2015 (9)
Financial year
01.01-31.12
Capital
2 520.00 €
Activity
01131 - Growing of vegetables (including gourds), roots and tubers, including mushrooms
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Eva Maran 11.08.1983 (41) | 100% - 2 520.00 EUR | Board member | - | |
Aivar Mäemets 05.06.1974 (50) | - | - | Indirect ownership |
2019 20.09.2020 | 2020 05.02.2021 | 2021 01.11.2022 | 2022 11.07.2023 | |
---|---|---|---|---|
Total Revenue | 25 € | 24 € | 0 € | 35 975 € |
Net profit (loss) for the period | 25 € | -6 353 € | -490 056 € | -405 989 € |
Profit Margin | 100% | -26471% | - | -1129% |
Current Assets | 2 586 € | 203 256 € | 63 324 € | 173 540 € |
Fixed Assets | - | - | 2 249 644 € | 4 415 351 € |
Total Assets | 2 586 € | 203 256 € | 2 312 968 € | 4 588 891 € |
Current Liabilities | - | 207 023 € | 254 791 € | 463 610 € |
Non Current Liabilities | - | - | 2 552 000 € | 4 562 790 € |
Total Liabilities | - | - | 2 806 791 € | 5 026 400 € |
Share Capital | - | - | - | - |
Equity | 2 586 € | -3 767 € | -493 823 € | -437 509 € |
Employees | 0 | 0 | 0 | 1 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 126 500 € | 1 206.62 € | 54.63 € | - |
2023 Q4 | - | 56.44 € | - | - |
2023 Q3 | - | - | - | - |
2023 Q2 | - | 12 457.36 € | 13 505.8 € | - |
2023 Q1 | 48 978 € | - | 16 026.75 € | 1 |
2022 Q4 | - | - | - | 1 |
2022 Q3 | - | - | - | - |
2022 Q2 | 2 975 € | - | - | - |
2022 Q1 | - | - | 11.97 € | - |
2021 Q4 | - | - | - | - |
2021 Q3 | - | - | - | - |
2021 Q2 | - | - | - | - |
2021 Q1 | - | - | - | - |
2020 Q4 | - | - | - | - |